U.S. Hemostasis & Tissue Sealing Agents Market Size, Share & Trends Report

U.S. Hemostasis & Tissue Sealing Agents Market Size, Share & Trends Analysis Report By Product (Topical Hemostat, Adhesive & Tissue Sealant), And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68040-242-2
Number of Pages: 80
Format: Electronic (PDF)

Historical Range: 2018 - 2023
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in U.S.
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.3. Competitive Insights
Chapter 3. U.S. Hemostasis & Tissue Sealing Agents Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic conditions
3.2.1.2. Rising preference towards minimally invasive surgical procedures
3.2.1.3. Growing geriatric population
3.2.2. Market restraint analysis
3.2.2.1. Product recalls
3.3. U.S. Hemostasis & Tissue Sealing Agents Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. U.S. Hemostasis & Tissue Sealing Agents Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Topical hemostats
4.1.2. Adhesive & tissue sealant
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. U.S. Hemostasis and Tissue Sealing Agents Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Topical hemostats
4.5.1.1. Topical hemostats market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2. Active
4.5.1.2.1. Active market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3. Mechanical
4.5.1.3.1. Mechanical market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.4. Flowable
4.5.1.4.1. Flowable market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.5. Adhesive & tissue sealant
4.5.1.5.1. Adhesive & tissue sealant market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Synthetic
4.5.2.1. Synthetic hemostats market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.2. Natural
4.5.2.2.1. Natural hemostats market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.3. Adhesion barrier
4.5.2.3.1. Adhesion barrier hemostats market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Competitive Landscape
5.1. Recent Developments & Impact Analysis, By Key Market Participants
5.2. Company/Competition Categorization
5.2.1. Innovators
5.3. Vendor Landscape
5.3.1. List of key distributors and channel partners
5.3.2. Key customers
5.3.3. Key company market share analysis, 2023
5.3.4. Johnson & Johnson
5.3.4.1. Company overview
5.3.4.2. Financial performance
5.3.4.3. Product benchmarking
5.3.4.4. Strategic initiatives
5.3.5. CryoLife Inc
5.3.5.1. Company overview
5.3.5.2. Financial performance
5.3.5.3. Product benchmarking
5.3.5.4. Strategic initiatives
5.3.6. Advance Medical Solution (AMS) Group Plc
5.3.6.1. Company overview
5.3.6.2. Financial performance
5.3.6.3. Product benchmarking
5.3.6.4. Strategic initiatives
5.3.7. Cohera Medical Inc
5.3.7.1. Company overview
5.3.7.2. Financial performance
5.3.7.3. Product benchmarking
5.3.7.4. Strategic initiatives
5.3.8. Integra Life Sciences Corporation
5.3.8.1. Company overview
5.3.8.2. Financial performance
5.3.8.3. Product benchmarking
5.3.8.4. Strategic initiatives
5.3.9. Pfizer Inc
5.3.9.1. Company overview
5.3.9.2. Financial performance
5.3.9.3. Product benchmarking
5.3.9.4. Strategic initiatives
5.3.10. C R Bard Inc
5.3.10.1. Company overview
5.3.10.2. Financial performance
5.3.10.3. Product benchmarking
5.3.10.4. Strategic initiatives
5.3.11. Cohesion Technologies Inc
5.3.11.1. Company overview
5.3.11.2. Financial performance
5.3.11.3. Product benchmarking
5.3.11.4. Strategic initiatives
5.3.12. HyperBranch Medical Technology
5.3.12.1. Company overview
5.3.12.2. Financial performance
5.3.12.3. Product benchmarking
5.3.12.4. Strategic initiatives
5.3.13. Biomet Inc
5.3.13.1. Company overview
5.3.13.2. Financial performance
5.3.13.3. Product benchmarking
5.3.13.4. Strategic initiatives
5.3.14. Covidien Plc
5.3.14.1. Company overview
5.3.14.2. Financial performance
5.3.14.3. Product benchmarking
5.3.14.4. Strategic initiatives
5.3.15. B Braun Medical Inc.
5.3.15.1. Company overview
5.3.15.2. Financial performance
5.3.15.3. Product benchmarking
5.3.15.4. Strategic initiatives
5.3.16. Smith & Nephew
5.3.16.1. Company overview
5.3.16.2. Financial performance
5.3.16.3. Product benchmarking
5.3.16.4. Strategic initiatives

List of Tables

Table 1. List of regulatory bodies for different countries
Table 2. Key companies’ product launches
Table 3. Key companies’ merger and acquisitions
Table 4. Key companies’ collaboration
Table 5. Other strategic initiatives of companies
Table 6. U.S. hemostasis and tissue sealing agents market, by product, 2018 - 2030 (USD Million)

List of Figures

Fig 1. U.S. Hemostasis and tissue sealing agents market segmentation
Fig 2. Market research process
Fig 3. Information procurement process
Fig 4. Primary research pattern
Fig 5. U.S. Hemostasis and tissue sealing agents market snapshot, 2023 (USD Million)
Fig 6. Segment snapshot, USD Million
Fig 7. Competitive landscape snapshot
Fig 8. Penetration & growth prospect mapping, by product
Fig 9. Market driver analysis (Current & future impact)
Fig 10. Market restraint analysis (Current & future impact)
Fig 11. Hemostasis and tissue sealing agents market, product outlook key takeaways (USD Million)
Fig 12. U.S. Hemostasis and tissue sealing agents market: Product movement analysis (USD Million), 2023 & 2030
Fig 13. Topical hemostat market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 14. Adhesive & tissue sealant market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig 15. U.S. hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.